H
Hemagen Diagnostics Inc
OTC:HMGN
Hemagen Diagnostics Inc
OTC:HMGN
Price:
0.0016
USD
Market Closed
Market Cap:
$24.8k
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
H
|
Hemagen Diagnostics Inc
OTC:HMGN
|
US |
|
Aftermath Silver Ltd
XTSX:AAG
|
CA |
|
M
|
Majestic Ideal Holdings Ltd
NASDAQ:MJID
|
HK |
|
S
|
Shanghai NAR Industrial Co Ltd
SZSE:002825
|
CN |
|
Andean Silver Ltd
ASX:ASL
|
AU |
|
C
|
Compal Electronics Inc
LSE:CEIR
|
TW |
Balance Sheet
Balance Sheet Decomposition
Hemagen Diagnostics Inc
Hemagen Diagnostics Inc
Balance Sheet Decomposition is not available for
Hemagen Diagnostics Inc
Hemagen Diagnostics Inc
Balance Sheet
Hemagen Diagnostics Inc
Hemagen Diagnostics Inc
Currency: USD
| Sep-1991 | Sep-1992 | Sep-1993 | Sep-1994 | Sep-1995 | Sep-1996 | Sep-1997 | Sep-1998 | Sep-1999 | Sep-2000 | Sep-2001 | Sep-2002 | Sep-2003 | Sep-2004 | Sep-2005 | Sep-2006 | Sep-2007 | Sep-2008 | Sep-2009 | Sep-2010 | Sep-2011 | Sep-2012 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||
| Cash & Cash Equivalents |
0
|
1
|
1
|
0
|
1
|
1
|
0
|
0
|
0
|
1
|
1
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash |
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
1
|
1
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
2
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
1
|
2
|
2
|
3
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
1
|
2
|
2
|
3
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
1
|
3
|
4
|
6
|
6
|
4
|
4
|
3
|
3
|
3
|
3
|
3
|
3
|
2
|
2
|
1
|
1
|
1
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
1
|
4
|
2
|
4
|
7
|
7
|
10
|
8
|
8
|
6
|
5
|
5
|
5
|
4
|
4
|
4
|
4
|
3
|
3
|
2
|
2
|
|
| PP&E Net |
0
|
0
|
1
|
2
|
3
|
3
|
3
|
4
|
4
|
3
|
2
|
2
|
1
|
0
|
1
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
1
|
2
|
3
|
3
|
3
|
4
|
4
|
3
|
2
|
2
|
1
|
0
|
1
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
1
|
2
|
2
|
3
|
4
|
5
|
5
|
6
|
7
|
7
|
7
|
6
|
6
|
6
|
6
|
6
|
6
|
7
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
2
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
2
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
2
+500%
|
5
+191%
|
5
-1%
|
7
+50%
|
12
+62%
|
12
-2%
|
16
+38%
|
12
-24%
|
11
-10%
|
8
-23%
|
7
-16%
|
6
-8%
|
6
-13%
|
5
-5%
|
4
-18%
|
4
-6%
|
5
+15%
|
4
-22%
|
3
-9%
|
3
-14%
|
2
-15%
|
|
| Liabilities | |||||||||||||||||||||||
| Accounts Payable |
0
|
0
|
0
|
1
|
1
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Short-Term Debt |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
4
|
3
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
5
|
0
|
0
|
1
|
1
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
1
|
1
|
1
|
2
|
2
|
1
|
5
|
7
|
4
|
2
|
2
|
1
|
2
|
3
|
1
|
2
|
6
|
1
|
1
|
2
|
2
|
|
| Long-Term Debt |
0
|
0
|
1
|
1
|
4
|
1
|
0
|
1
|
0
|
1
|
2
|
2
|
3
|
4
|
4
|
4
|
4
|
0
|
4
|
4
|
4
|
4
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
1
+378%
|
1
+2%
|
2
+96%
|
5
+147%
|
2
-56%
|
2
-36%
|
6
+283%
|
7
+25%
|
5
-26%
|
4
-32%
|
4
+6%
|
5
+20%
|
5
+17%
|
6
+19%
|
5
-20%
|
6
+10%
|
6
+4%
|
6
-6%
|
5
-5%
|
6
+7%
|
6
+8%
|
|
| Equity | |||||||||||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
0
|
0
|
1
|
2
|
3
|
4
|
3
|
3
|
9
|
14
|
16
|
18
|
19
|
22
|
24
|
24
|
24
|
24
|
25
|
25
|
26
|
27
|
|
| Additional Paid In Capital |
0
|
1
|
5
|
5
|
5
|
13
|
13
|
13
|
13
|
19
|
21
|
21
|
21
|
23
|
23
|
23
|
23
|
23
|
23
|
23
|
23
|
23
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
1
+1 350%
|
4
+548%
|
3
-29%
|
2
-30%
|
9
+404%
|
10
+6%
|
10
+1%
|
5
-52%
|
6
+14%
|
5
-15%
|
3
-33%
|
2
-40%
|
0
-86%
|
1
N/A
|
1
+30%
|
1
-111%
|
1
+27%
|
2
-63%
|
2
-4%
|
3
-45%
|
4
-32%
|
|
| Total Liabilities & Equity |
0
N/A
|
2
+500%
|
5
+191%
|
5
-1%
|
7
+50%
|
12
+62%
|
12
-2%
|
16
+38%
|
12
-24%
|
11
-10%
|
8
-23%
|
7
-16%
|
6
-8%
|
6
-13%
|
5
-5%
|
4
-18%
|
4
-6%
|
5
+15%
|
4
-22%
|
3
-9%
|
3
-14%
|
2
-15%
|
|
| Shares Outstanding | |||||||||||||||||||||||
| Common Shares Outstanding |
2
|
2
|
3
|
3
|
3
|
8
|
8
|
8
|
8
|
10
|
10
|
10
|
10
|
15
|
15
|
15
|
15
|
15
|
15
|
15
|
15
|
16
|
|
Switch to:
Switch to:
See Also
Discover More
